MedTech News
.................... by Andrew Celentano
New Ultrasound Imaging Technique Helps Doctors See Inflammatory Bowel Disease Activity at the Bedside with no Sedation or Radiation
WASHINGTON, March 31, 2025 /PRNewswire/ — MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn’s disease and ulcerative colitis, patients are traditionally monitored with blood tests, stool studies, MRI or CT scans, and colonoscopies. Those kinds of tests can require bowel preparation, sedation, anesthesia, and radiation.
AZmed Receives Two New FDA Clearances for Its AI-Powered Chest X-ray Solution
PARIS, March 31, 2025 /PRNewswire/ — AZmed, one of the leading AI companies in medical imaging, today announced that it has received two new U.S. Food and Drug Administration (FDA) clearances for its AI tool AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest X-rays for lung nodules and triage capabilities for pneumothorax and pleural effusion.
Abbott snags early CE mark for Volt PFA device
With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.
Feeling the future: New wearable tech simulates realistic touch
Device goes beyond the buzz to create a sophisticated variety of haptic sensations
‘Sky is not falling’ over 23andMe bankruptcy
Social media has far more intrusive information than genomic data, genetic justice expert says
SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.
Enable Injections wins CE mark for enFuse drug delivery device
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.
Silk sponges instead of animal testing: How a 3D cell culture system could advance cancer diagnostics
A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with company partner DOC Medikus GmbH, has developed an innovative bioanalytical test system for radiopharmaceutical drug candidates for cancer diagnosis and therapy.